Eagle Boston Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | $1.16M | Sell |
8,146
-19,950
| -71% | -$2.83M | 1.32% | 29 |
|
|
2019
Q1 | $4.08M | Sell |
28,096
-9,815
| -26% | -$1.43M | 1.78% | 7 |
|
|
2018
Q4 | $4.29M | Sell |
37,911
-69,684
| -65% | -$7.89M | 1.49% | 14 |
|
|
2018
Q3 | $14.5M | Buy |
107,595
+2,202
| +2% | +$296K | 1.3% | 22 |
|
|
2018
Q2 | $11.8M | Buy |
105,393
+8,598
| +9% | +$965K | 1.09% | 37 |
|
|
2018
Q1 | $10.3M | Buy |
96,795
+5,493
| +6% | +$586K | 1.03% | 42 |
|
|
2017
Q4 | $9.99M | Buy |
91,302
+4,884
| +6% | +$535K | 1% | 40 |
|
|
2017
Q3 | $9.41M | Buy |
86,418
+1,918
| +2% | +$209K | 0.97% | 48 |
|
|
2017
Q2 | $8.55M | Sell |
84,500
-193
| -0.2% | -$19.5K | 0.93% | 47 |
|
|
2017
Q1 | $7.62M | Buy |
84,693
+4,300
| +5% | +$387K | 0.85% | 53 |
|
|
2016
Q4 | $6.13M | Buy |
80,393
+37
| +0% | +$2.82K | 0.73% | 64 |
|
|
2016
Q3 | $6.7M | Buy |
80,356
+643
| +0.8% | +$53.6K | 0.86% | 52 |
|
|
2016
Q2 | $6.57M | Buy |
79,713
+1,992
| +3% | +$164K | 0.89% | 50 |
|
|
2016
Q1 | $5.9M | Buy |
77,721
+2,445
| +3% | +$186K | 0.82% | 56 |
|
|
2015
Q4 | $6.05M | Sell |
75,276
-3,458
| -4% | -$278K | 0.85% | 54 |
|
|
2015
Q3 | $5M | Buy |
78,734
+3,038
| +4% | +$193K | 0.67% | 70 |
|
|
2015
Q2 | $5.32M | Sell |
75,696
-29,929
| -28% | -$2.11M | 0.67% | 71 |
|
|
2015
Q1 | $8.38M | Sell |
105,625
-44,968
| -30% | -$3.57M | 0.7% | 58 |
|
|
2014
Q4 | $9.58M | Sell |
150,593
-46,968
| -24% | -$2.99M | 0.63% | 76 |
|
|
2014
Q3 | $11.8M | Sell |
197,561
-7,682
| -4% | -$459K | 0.65% | 59 |
|
|
2014
Q2 | $11M | Sell |
205,243
-5,982
| -3% | -$320K | 0.55% | 80 |
|
|
2014
Q1 | $12.7M | Sell |
211,225
-10,976
| -5% | -$662K | 0.63% | 71 |
|
|
2013
Q4 | $11.8M | Buy |
222,201
+64,697
| +41% | +$3.43M | 0.57% | 69 |
|
|
2013
Q3 | $7.28M | Sell |
157,504
-2,988
| -2% | -$138K | 0.44% | 83 |
|
|
2013
Q2 | $6.58M | Buy |
+160,492
| New | +$6.58M | 0.44% | 88 |
|